Evofem Biosciences Inc


Prices are adjusted according to historical splits.

Evofem Biosciences Inc Stock Price


Today's Low:
Today's High:
Open Price:
52W Low:
52W High:
Prev. Close:

Company Statistics

Market Cap.:
$6.21 million
Book Value:
Revenue TTM:
$20.23 million
Operating Margin TTM:
Gross Profit TTM:
$4.19 million
Profit Margin:
Return on Assets TTM:
Return on Equity TTM:

Company Profile

Evofem Biosciences Inc had its IPO on 2018-01-17 under the ticker symbol EVFM.

The company operates in the Healthcare sector and Biotechnology industry. Evofem Biosciences Inc has a staff strength of 119 employees.

Stock update

Shares of Evofem Biosciences Inc opened at $0.03 at the start of the last trading session i.e. 2023-03-24.

The stocks traded within a range of $0.02 - $0.04, and closed at $0.02.

This is a -29.14% slip from the previous day's closing price.

A total volume of 17,174,669 shares were traded at the close of the day’s session.

In the last one week, shares of Evofem Biosciences Inc have increased by +65.33%.

Evofem Biosciences Inc's Key Ratios

Evofem Biosciences Inc has a market cap of $6.21 million, indicating a price to book ratio of 8.372 and a price to sales ratio of 0.42.

In the last 12-months Evofem Biosciences Inc’s revenue was $20.23 million with a gross profit of $4.19 million and an EBITDA of $-108440000. The EBITDA ratio measures Evofem Biosciences Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Evofem Biosciences Inc’s operating margin was -541.33% while its return on assets stood at -124.75% with a return of equity of -387.27%.

In Q4, Evofem Biosciences Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 272.1%.

Evofem Biosciences Inc’s PE and PEG Ratio

Forward PE
Trailing PE

Its diluted EPS in the last 12-months stands at $-14.61 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Evofem Biosciences Inc’s profitability.

Evofem Biosciences Inc stock is trading at a EV to sales ratio of 7.2023 and a EV to EBITDA ratio of -0.8469. Its price to sales ratio in the trailing 12-months stood at 0.42.

Evofem Biosciences Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$42.28 million
Total Liabilities
$116.71 million
Operating Cash Flow
Capital Expenditure
Dividend Payout Ratio

Evofem Biosciences Inc ended 2023 with $42.28 million in total assets and $0 in total liabilities. Its intangible assets were valued at $42.28 million while shareholder equity stood at $-78044000.00.

Evofem Biosciences Inc ended 2023 with $0 in deferred long-term liabilities, $116.71 million in other current liabilities, 10000.00 in common stock, $-930358000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $7.75 million and cash and short-term investments were $7.75 million. The company’s total short-term debt was $80,127,000 while long-term debt stood at $0.

Evofem Biosciences Inc’s total current assets stands at $31.79 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $12.76 million compared to accounts payable of $14.54 million and inventory worth $5.18 million.

In 2023, Evofem Biosciences Inc's operating cash flow was $0 while its capital expenditure stood at $136000.

Comparatively, Evofem Biosciences Inc paid $0 in dividends in 2023.

Other key metrics

Current Trading Price
52-Week High
52-Week Low
Analyst Target Price

Evofem Biosciences Inc stock is currently trading at $0.02 per share. It touched a 52-week high of $5.7 and a 52-week low of $5.7. Analysts tracking the stock have a 12-month average target price of $1.8.

Its 50-day moving average was $0.04 and 200-day moving average was $0.27 The short ratio stood at 0.19 indicating a short percent outstanding of 0%.

Around 13.5% of the company’s stock are held by insiders while 446.4% are held by institutions.

Frequently Asked Questions About Evofem Biosciences Inc

The stock symbol (also called stock or share ticker) of Evofem Biosciences Inc is EVFM

The IPO of Evofem Biosciences Inc took place on 2018-01-17

Similar Industry Stocks (Biotechnology)

Last Price
ODP Corp (ODP)

Most Active

Last Price

Top Gainers

Last Price

Top Losers

Last Price
Imara Inc (IMRA)


Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women’s sexual and reproductive health. Its commercial product is Phexxi, a vaginal gel for the prevention of pregnancy. The company is also involved in the development of EVO100, an antimicrobial vaginal gel for the prevention of urogenital transmission of Chlamydia trachomatis infection and Neisseria gonorrhoeae infection in women. Evofem Biosciences, Inc. is headquartered in San Diego, California.


12400 High Bluff Drive, San Diego, CA, United States, 92130